Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Chordia Therapeutics, Inc.

Clinical trials sponsored by Chordia Therapeutics, Inc., explained in plain language.

Chordia Therapeutics 190A TOKYO

Biotech developing small-molecule cancer drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New pill shows promise for tough blood cancers

Disease control Recruiting now

This study tests an experimental drug called CTX-712 in people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) that have come back or not responded to treatment. The drug is taken by mouth once or twice weekly. The trial aims to find the safest dose and see i…

Phase: PHASE1, PHASE2 • Sponsor: Chordia Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC